A male child with metabolic acidosis was diagnosed as having dihydrolipoamide dehydrognase E3 deficiency. E3 activity of the proband's cultured fibroblasts and blood lymphocytes was 3-9% of normal, while in the parent's Ž . lymphocytes it was about 60% of normal. The proband's pyruvate dehydrogenase complex PDC and the a-ketoglutarate dehydrogenase complex activities from cultured skin fibroblasts were 12% and 6% of normal, respectively. PDC activity in the parents cultured fibroblasts was 25-31% of normal. Western and Northern blot analyses showed similar quantities of E3 protein and mRNA in cultured fibroblasts from the proband and his parents. DNA sequencing of cloned full-length E3 cDNAs, from the proband and the parents, showed two mutations on different alleles of proband were inherited from the Ž . parents. One mutation is a three nucleotide AGG deletion, from the mother, resulting in deletion of Gly101 in the FAD Ž . binding domain. The other mutation is a nucleotide substitution G to A , from the father, leading to substitution of Lys for Glu340 in the central domain. The same deletion mutation was found in E3 cDNA from a chorionic villus sample and cultured fibroblasts obtained from the mother's subsequent offspring. This finding illustrates the possiblilty of successful prenatal diagnosis of E3 deficiency utilizing mutations characterized prior to initiation of pregnancy. q 1997 Elsevier Science B.V.
.w x Ž BCKDC 1 . E3 is also a component known as the . w x L protein of the glycine cleavage system 2 . The human E3 gene is located on chromosome 7, within w x bands q31-q32 3 . This gene encodes a 509 amino acid protein, of which the N-terminal 35 amino acids form a leader sequence having an a-helical structure w x that is cleaved during import into mitochondria 4 . The active enzyme is a homodimer of 51 kDa sub-Ž units with 4 distinctive subdomain structures FAD binding, NAD q binding, central, and interface do-. mains and has 2 identical active sites composed of specific amino acid residues from both subunits. During catalysis, electrons are sequentially transferred from a dihydrolipoyl moiety bound to the substrate protein to the redox disulfide in the E3 protein, the FAD cofactor, and finally to NAD q to generate NADH.
Because E3 is the common component in these complexes, lack of functional E3 causes reduction in w x the activities in PDC, KGDC, and BCKDC 1 . E3 deficiency leads to development of lactic acidosis and neurological degeneration as well as elevated levels of plasma branched-chain amino acids and urinary excretion of the respective a-keto and a-hydroxy w x acids 5 . E3 deficiency has been well documented in w x at least 15 patients 6-15 , but specific mutations in the coding region have been reported in only three w x patients 16-18 . In this paper, we report 2 additional mutations, a deletion and a substitution, together causing E3 deficiency and separately causing partial deficiency in the heterozygous parents.
Clinical history
The proband was a male child who was the product of a 42 week pregnancy, with a birth weight of 3.6 kg. He appeared normal after birth until the 3rd Ž . gressive optic atrophy. D,L-Lipoic acid 50 mgrkgrd was administrated for 4 months without apparent clinical or biochemical benefit. He died at age of 5 1r2 years following an acute illness. A limited autopsy was performed 2 h after death to obtain tissue samples, which were frozen.
The mother became pregnant again following the diagnosis of E3 deficiency in her son. Chorionic villus sampling was performed at approximately 6 weeks of gestation; part of this sample was frozen and assayed directly and another portion was cultured for growth of fibroblasts. She gave birth to a healthy Ž female infant at 39 week gestation birth weight . 3.9 kg . There was no evidence in this child of any of the clinical problems which had affected her elder brother. Blood was obtained at birth from the umbilical cord for isolation of lymphocytes, and again at age 2 months; a skin biopsy was performed for growth of fibroblasts. This child has remained in ( ) good health and is functioning normally at age of 7 years. The parents also have remained in good health and are functioning at high intellectual levels.
Materials and methods

Cell and tissue samples and enzyme assays
All samples from human subjects were obtained according to protocols approved by the Institutional Review Board of University Hospitals of Cleveland, with the informed consent of the parents of these two children. Isolation of lymphocytes, culture of fibroblasts, and assays of the activities of PDC, KGDC, and w x E3 were performed as previously described 17,19,20 . Control sample data were collected over several years through the Center for Inherited Disorders of Energy Metabolism, Case Western Reserve University, utilizing identical methods of sample collection and assays to those used for the results shown here; concurrent control samples were run with each assay.
Immunoblotting
14 mg of mitochondrial protein obtained from cultured fibroblasts of a normal control, the proband and his two parents were run on 12% sodium dodecyl Ž . sulphate SDS polyacrylamide gel electrophoresis. The proteins were transferred to a nitrocellulose membrane using an electroblotting apparatus at 100 V for 1 h, and immunoblotting was done as previously w x described 17 . The E3 immunospecific bands were detected by E3 specific antibody raised against Ž . porcine E3 and by chemiluminescence Du Pont . As a standard, 25 ng of highly purified human E3 was included.
RNA blotting
Total RNA was extracted from cultured fibroblasts of the patient and a control by the guanidium thiow x cyanate method 21 . 25 mg of total RNA was separated by electrophoresis in 0.8% agarose gel containing 50% formaldehyde and subsequently transferred w x to a Genescreen membrane 22 . The blot was prehy-X w bridized with 20 mM piperazine-N, N -bis 2-ethanex sulfonic acid , pH 6.4, 2 mM EDTA, 0.8 M NaCl, 50% formamide, and 100 mgrml salmon sperm DNA at 428C overnight. The membrane was probed with a X w 32 x 1.1 kb 5 fragment of E3 cDNA labeled with P -aw x dCTP by the random primer reaction 23 . The blot was washed with 2 = SSCr1% SDS, 1 = SSCr0.1% SDS, 0.1 = SSCr0.1% SDS at 508C, air dried, and autoradiographed.
Construction of E3 cDNAs and DNA sequencing
E3 cDNA was prepared by reverse transcription Ž . and the polymerase chain reaction RT-PCR as prew x viously described 17 . Total RNA was isolated from cultured fibroblasts of a control, the proband, the proband's younger sister, and the proband's parents Ž . as well as a frozen chorionic villus sample 10 mg obtained from the mother's subsequent pregnancy, Ž using the ''Perfect RNA'' isolation kit 5 Prime to 3 . Prime . Reverse transcription was carried out for 1 h at 438C in a 20 ml reaction mixture which contained Ž . 1 mg of total RNA, 1 mg of oligo d T primer, 16 0.5 nmoles of dNTP mixture, 20 mM dithiothreitol, and 1 unit of SuperScript II reverse transcriptase Ž . Life Technologies , in the reaction buffer supplied by the manufacturer. Using the oligo dT primed first strand cDNAs as templates, E3 cDNAs for each specimen were specifically amplified by PCR using a Ž X pair of primers sense, 5 -GCGCGCGGATCCG-GAGGTGAAAGTATTGGCGG-3 X ; antisense, 5 X -GCGCGCGGATCCTCAAAAGTTGATTGATTT-X . GCC-3 that generate BamHI restriction sites at both w x ends of the full-length E3 cDNA 17 . For the proband's E3 cDNA analysis, the amplified 1.5 kb fragment was isolated from agarose gel, cut with BamHI, and ligated with pBluescript SK q vector digested with the same enzyme. After confirmation, the recombinant pBluescript vector containing E3 cDNA was transformed into E. coli XL1-Blue competent cells. Plasmids containing the appropriate size DNA inserts were sequenced 4 times using Seque-Ž . nase kit ver. 2.0 US Biochemicals , using 4 pairs of overlapping primers and pBluescript primers for the entire E3 cDNA. To confirm the proband's mutations and the inheritance of these mutations from the par- ents, direct DNA sequencing was performed with genomic DNAs of the proband and the parents in the regions surrounding the mutations.
Results
Enzyme assays
Assays of E3 in fresh blood lymphocytes and cultured skin fibroblasts from the proband were 9% and 3% respectively of the mean activity of controls Ž . Table 1 . In lymphocytes from his mother and fa- ther, E3 activities were 61% and 57% of controls, respectively, and in skin fibroblasts, E3 activities Ž . were 38% and 22% Table 1 . PDC activity was 13% of controls in lymphocytes from the proband but was Ž not reduced in lymphocytes from the parents 127-. 130% . On the other hand, PDC activity was 12% of controls in cultured skin fibroblasts from the proband and well below the range of controls in fibroblasts Ž from the mother and father 31% and 25% respec-. tively . Therefore, the effect of partial E3 deficiency Ž . in the parents on PDC activity was more severe in cultured fibroblasts than in fresh lymphocytes. The activity of citrate synthase, used as an internal mitochondrial control, was about half of that in controls in skin fibroblasts from the proband and both of his Ž . parents Table 1 .
KGDC activity was also greatly reduced in skin fibroblasts from the proband, corresponding to 6% of Ž . controls Table 2 . The relatively low activities of PDC and KGDC found in the proband's E3 deficient cultured skin fibroblasts are consistent with other tissues assayed. In heart, skeletal muscle, and liver samples obtained very soon after death, E3 activity was 4-11% of controls, PDC activity was 14-22%, Ž . and KGDC activity was only 1-3% Table 2 . In all cells and tissue samples assayed, the effect of E3 deficiency was greater on KGDC than on PDC.
Western and Northern blot analyses
The results of immunoblotting demonstrate that there was no difference in the content of E3 in cultured skin fibroblasts from the proband or his Ž . parents compared to that of a control subject Fig. 1 . Despite the loss of E3 activity, the level of expressed E3 protein seems not to be changed in the proband and his parents. Although immunoreactive E3 was present in cultured skin fibroblasts, this was not the case for postmortem liver, heart, or skeletal muscle samples, in which no E3 was detectable by immuno-Ž . blotting data not shown . The difference presumably reflects the variable stability of this mutant form of E3 in cultured cells vs. postmortem tissues, as ordinarily E3 is relatively stable postmortem.
RNA blot analysis showed double bands of E3 mRNAs which were 2.2 and 2.4 kb in size from both the proband's and control cells; there was no significant difference in the intensity of these bands be-Ž . tween the subjects results not shown . These findings indicate that E3 deficiency was not caused by a lack of E3 mRNA.
DNA sequencing of E3 cDNAs
Two mutations were found in separate clones of the proband's full-length E3 cDNA coding sequence Ž Ž .. Fig. 2 A . One allele of the patient's E3, found in 7 Ž separate clones, showed a 3 nucleotide deletion 455th to 457th, AGG; third nucleotide of 100th codon for threonine and first two nucleotides of the 101st codon . for glycine of the normal E3 coding sequence resulting in the deletion of Gly101. The other allele of the proband's E3, found in 6 separate clones, had a Ž substitution of A for G T for C in the antisense . sequence at the 1173rd nucleotide, which results in Ž . substitution of the codon for Glu340 GAA with Ž . Lys340 AAA . DNA sequencing of the proband's E3 cDNA was repeated 3 times for each RT-PCR generated product, and 3 independent RT-PCR reactions were performed to eliminate any possible Sequenase or polymerase error. In both the proband's Ž . 'Allele 1' and 'Allele 2' are used to distinguish the two types of cloned E3 cDNAs, based on DNA sequencing. A Comparison of DNA sequences of cloned E3 cDNAs around the mutation between a control and the proband. Deleted nucleotides are designated with a solid Ž . bar. The substituted nucleotide in the proband is shown with an arrow. B Direct genomic DNA PCR sequencing of E3 gene from the proband and his parents. Since a three nucleotide deletion mutation caused a frame shift of DNA sequences from both the proband and his mother, overlapping sequences are shown in parts. For the substitution mutation found in both the proband and his father, only one Ž . overlapping sequence is identified. C DNA sequencing data of cloned E3 cDNAs from a chorionic villus sample and cultured skin fibroblasts from the proband's sister compared with a control. ( ) and the mother's genomic DNAs, direct sequencing showed overlapping DNA sequences starting from the 455th nucleotide caused by deletion of 3 nucleotides in one of the two alleles, indicating that the Ž deletion mutation was inherited from the mother Fig.  Ž ..  2 B . In direct sequencing of both the proband's and Ž father's genomic DNAs, both G and A C and T in . the antisense sequence bands were found at the 1173rd nucleotide, demonstrating that the substitution Ž Ž .. mutation was inherited from the father Fig. 2 B . 
Analysis of prenatal samples
Direct assay of E3 in a homogenate of the frozen chorionic villus sample from the mother's subsequent pregnancy showed activity of 45% of controls, while Ž . PDC activity was 93% Table 3 . Later, fibroblasts cultured from this chorionic villus sample were assayed and showed E3 and PDC activities equivalent Ž . to 64% and 73% of controls, respectively Table 3 . In lymphocytes obtained from cord blood and at age 2 months, E3 was 39% of controls, whereas PDC Ž . activity was normal 77% of controls , while in cultured skin fibroblasts from this child, E3 activity was Ž 26% of controls and PDC activity was 28% Table  . 1 . These assays of E3 activity in samples from the daughter are consistent with a heterozygous condition. The difference between the consequences of reduced E3 activity on PDC in lymphocytes and fibroblasts is similar to what was found in the parents. Citrate synthase activity was also lower in fibroblasts. Mutational analysis of cloned E3 cDNA prepared from the frozen chorionic villus sample showed the same deletion mutation as found in the mother's E3 Ž missing 3 nucleotides AGG, from 455th to 457th, . Ž Ž .. resulting in the deletion of Gly101 Fig. 2 C . This mutation was also confirmed in E3 cDNA from Ž Ž .. cultured skin fibroblasts from the sister Fig. 2 C . 
Discussion
The severe clinical consequences in this child with a fatal form of E3 deficiency have been described in most of the other reported cases of this disorder w x 6-12,24,25 . While there is considerable clinical Ž . and probably genetic heterogeneity within this small population, the predominant phenotypic consequences are neurological, including impaired mental development, seizures, and degenerative deterioration w x 26 . The predictable metabolic manifestations of increased lactic, pyruvic, a-ketoglutaric, and branched-chain a-keto and a-hydroxy organic acids were all present, but the metabolic findings in this case were complex, which also has been true for other cases of E3 deficiency. In contrast to one previous case who appeared to benefit from adminisw x tration of D,L-lipoic acid 9 , there was no evidence for a beneficial effect of use of this agent in the present case.
The partial reduction of E3 activity in the heterozygous parents and sister has a less severe effect on PDC activity in blood lymphocytes or the chorionic villus sample than in cultured fibroblasts. Reduction of PDC activity has been observed previously in w x skin fibroblasts from E3 heterozygotes 17,27 . This difference may be due to the normally higher ratios Ž . of E3 to PDC activity in lymphocytes 40:1 and Ž . Ž . chorionic villus 72:1 than in fibroblasts 23:1 . The lack of excess E3 in fibroblasts may be related to the observation that citrate synthase is also lower in these deficient and heterozygous cells, but the mechanism is not known.
In this paper, we have identified two new mutations, a 3 base pair deletion and a base substitution, in the E3-deficient male proband. These two mutations are located on different alleles. These mutations are significant because they affect the catalytic function of the E3 protein without affecting its content Ž . Fig. 1 or the content of E3 mRNA in cultured skin fibroblasts. We found the mutations were inherited from heterozygous parents. Those findings depended on systematic characterization of full-length E3 cD-NAs generated by RT-PCR from RNA isolated from cultured fibroblasts. DNA sequencing data and significantly reduced activities of E3, PDC and KGDC in the patient as well as a moderate reduction in the parent's cells confirm that these mutations were inherited from the parents in an autosomal recessive Ž . manner Table 1 .
The mutations found in this patient, which affect conserved amino acids, are located in the a-helixes Ž . of the FAD domain Gly101del and the central Ž . domain Glu340Lys , based on amino acid homology . among E3s from various species Fig. 3 . The dele-Ž . tion mutation inherited from the mother Gly101 , located within the highly conserved amino acid residues of the 3rd a-helix of the FAD binding domain, probably causes a regional structural change which may affect the binding of FAD, resulting in the loss of E3 activity. Glycine, a small, non-polar residue, is not likely to be involved in inter-side chain Ž . relationships. The substitution mutation Glu340Lys , inherited from the father, replaces a smaller, negatively charged side chain of an amino acid in a conserved a-helix with a bulky, positively charged side chain. Since Glu340 is located in the hydrophilic Ž . side of the a-helix Fig. 3 , this reversal in charge of the side chain would be expected to exert more effect on E3 activity than a local structural change due to the size difference between the two amino acids.
Reduced E3 activity in fibroblasts from the father indicates that this substitution mutation causes a sig-Ž . nificant reduction about 50% of E3 activity. Based on the available X-ray crystal structure of E3 from w x three prokaryotic sources 29-31 , it is not possible to discern the functions of these two amino acids in human E3 at the present time. The characterization of overexpressed recombinant mutant E3s would shed light on the possible roles of these two amino acids in human E3.
The heterozygous status of the proband's sister was detected in utero by assay of E3 activity in a chorionic villus sample and confirmed at birth in cord blood lymphocytes, as well as cultured fibroblasts from the chorionic villus and skin biopsies. To our knowledge, this is the first reported example of successful prenatal diagnostic testing for E3 deficiency. 
Ž .
